journal article
Open Access
Jun 07, 2023
Comprehensive Analysis of Hemophilia A (CAHEA): Towards Full Characterization of the F8 Gene Variants by Long-Read Sequencing
Abstract
Background Hemophilia A (HA) is the most frequently occurring X-linked bleeding disorder caused by heterogeneous variants in the F8 gene, one of the largest genes known. Conventional molecular analysis of F8 requires a combination of assays, usually including long-range polymerase chain reaction (LR-PCR) or inverse-PCR for inversions, Sanger sequencing or next-generation sequencing for single-nucleotide variants (SNVs) and indels, and multiplex ligation-dependent probe amplification for large deletions or duplications.
Materials and Methods This study aimed to develop a LR-PCR and long-read sequencing-based assay termed comprehensive analysis of hemophilia A (CAHEA) for full characterization of F8 variants. The performance of CAHEA was evaluated in 272 samples from 131 HA pedigrees with a wide spectrum of F8 variants by comparing to conventional molecular assays.
Results CAHEA identified F8 variants in all the 131 pedigrees, including 35 intron 22-related gene rearrangements, 3 intron 1 inversion (Inv1), 85 SNVs and indels, 1 large insertion, and 7 large deletions. The accuracy of CAHEA was also confirmed in another set of 14 HA pedigrees. Compared with the conventional methods combined altogether, CAHEA assay demonstrated 100% sensitivity and specificity for identifying various types of F8 variants and had the advantages of directly determining the break regions/points of large inversions, insertions, and deletions, which enabled analyzing the mechanisms of recombination at the junction sites and pathogenicity of the variants.
Conclusion CAHEA represents a comprehensive assay toward full characterization of F8 variants including intron 22 and intron 1 inversions, SNVs/indels, and large insertions and deletions, greatly improving the genetic screening and diagnosis for HA.
Materials and Methods This study aimed to develop a LR-PCR and long-read sequencing-based assay termed comprehensive analysis of hemophilia A (CAHEA) for full characterization of F8 variants. The performance of CAHEA was evaluated in 272 samples from 131 HA pedigrees with a wide spectrum of F8 variants by comparing to conventional molecular assays.
Results CAHEA identified F8 variants in all the 131 pedigrees, including 35 intron 22-related gene rearrangements, 3 intron 1 inversion (Inv1), 85 SNVs and indels, 1 large insertion, and 7 large deletions. The accuracy of CAHEA was also confirmed in another set of 14 HA pedigrees. Compared with the conventional methods combined altogether, CAHEA assay demonstrated 100% sensitivity and specificity for identifying various types of F8 variants and had the advantages of directly determining the break regions/points of large inversions, insertions, and deletions, which enabled analyzing the mechanisms of recombination at the junction sites and pathogenicity of the variants.
Conclusion CAHEA represents a comprehensive assay toward full characterization of F8 variants including intron 22 and intron 1 inversions, SNVs/indels, and large insertions and deletions, greatly improving the genetic screening and diagnosis for HA.
Topics
No keywords indexed for this article. Browse by subject →
References
35
[1]
P H Bolton-Maggs "Haemophilias A and B" Lancet (2003) 10.1016/s0140-6736(03)13405-8
[2]
G C White II "Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis" Thromb Haemost (2001) 10.1055/s-0037-1615621
[3]
R D Bagnall "Int22h-related inversions causing hemophilia A: a novel insight into their origin and a new more discriminant PCR test for their detection" J Thromb Haemost (2006) 10.1111/j.1538-7836.2006.01840.x
[4]
R D Bagnall "Polymorphism and hemophilia A causing inversions in distal Xq28: a complex picture" J Thromb Haemost (2005) 10.1111/j.1538-7836.2005.01566.x
[5]
L C Rossetti "Eighteen years of molecular genotyping the hemophilia inversion hotspot: from southern blot to inverse shifting-PCR" Int J Mol Sci (2011) 10.3390/ijms12107271
[6]
C Mühle "Recurrent inversion with concomitant deletion and insertion events in the coagulation factor VIII gene suggests a new mechanism for X-chromosomal rearrangements causing hemophilia A" Hum Mutat (2007) 10.1002/humu.9506
[7]
J Fujita "A possible mechanism for Inv22-related F8 large deletions in severe hemophilia A patients with high responding factor VIII inhibitors" J Thromb Haemost (2012) 10.1111/j.1538-7836.2012.04897.x
[8]
C Chen "Complex recombination with deletion in the F8 and duplication in the TMLHE mediated by int22h copies during early embryogenesis" Thromb Haemost (2017) 10.1160/th17-01-0046
[9]
S E Antonarakis "Factor VIII gene inversions in severe hemophilia A: results of an international consortium study" Blood (1995) 10.1182/blood.v86.6.2206.bloodjournal8662206
[10]
R D Bagnall "Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A" Blood (2002) 10.1182/blood.v99.1.168
[11]
M M Abelleyro "Molecular insights into the mechanism of nonrecurrent F8 structural variants: full breakpoint characterization and bioinformatics of DNA elements implicated in the upmost severe phenotype in hemophilia A" Hum Mutat (2020) 10.1002/humu.23977
[12]
N Lannoy "Principles of genetic variations and molecular diseases: applications in hemophilia A" Crit Rev Oncol Hematol (2016) 10.1016/j.critrevonc.2016.04.005
[13]
Y Jourdy "Comprehensive analysis of F8 large deletions: characterization of full breakpoint junctions and description of a possible DNA breakage hotspot in intron 6" J Thromb Haemost (2022) 10.1111/jth.15835
[14]
A B Payne "The CDC Hemophilia A Mutation Project (CHAMP) mutation list: a new online resource" Hum Mutat (2013) 10.1002/humu.22247
[15]
J H McVey "The European Association for Haemophilia and Allied Disorders (EAHAD) coagulation factor variant databases: important resources for haemostasis clinicians and researchers" Haemophilia (2020) 10.1111/hae.13947
[16]
G Kemball-Cook "The factor VIII structure and mutation resource site: HAMSTeRS version 4" Nucleic Acids Res (1998) 10.1093/nar/26.1.216
[17]
Single-Tube Polymerase Chain Reaction for Rapid Diagnosis of the Inversion Hotspot of Mutation in Hemophilia A
Qiang Liu, Guity Nozari, Steve S. Sommer
Blood
1998
10.1182/blood.v92.4.1458
[18]
L C Rossetti "Genotyping the hemophilia inversion hotspot by use of inverse PCR" Clin Chem (2005) 10.1373/clinchem.2004.046490
[19]
L C Rossetti "Developing a new generation of tests for genotyping hemophilia-causative rearrangements involving int22h and int1h hotspots in the factor VIII gene" J Thromb Haemost (2008) 10.1111/j.1538-7836.2008.02926.x
[20]
R Santacroce "Identification of 217 unreported mutations in the F8 gene in a group of 1,410 unselected Italian patients with hemophilia A" J Hum Genet (2008) 10.1007/s10038-007-0238-y
[21]
M Citron "High throughput mutation screening of the factor VIII gene (F8C) in hemophilia A: 37 novel mutations and genotype-phenotype correlation" Hum Mutat (2002) 10.1002/humu.10119
[22]
J Chen "The spectrum of FVIII gene variants detected by next generation sequencing in 236 Chinese non-inversion hemophilia A pedigrees" Thromb Res (2021) 10.1016/j.thromres.2021.02.027
[23]
H Inaba "Identification of deep intronic individual variants in patients with hemophilia A by next-generation sequencing of the whole factor VIII gene" Res Pract Thromb Haemost (2017) 10.1002/rth2.12031
[24]
B Pezeshkpoor "Deep intronic ‘mutations’ cause hemophilia A: application of next generation sequencing in patients without detectable mutation in F8 cDNA" J Thromb Haemost (2013) 10.1111/jth.12339
[25]
S Rost "Detection of large duplications within the factor VIII gene by MLPA" J Thromb Haemost (2008) 10.1111/j.1538-7836.2008.03125.x
[26]
Y Lu "Spectrum and origin of mutations in sporadic cases of haemophilia A in China" Haemophilia (2018) 10.1111/hae.13402
[27]
Y Repessé "Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development" J Thromb Haemost (2007) 10.1111/j.1538-7836.2007.02591.x
[28]
Z Guo "Spectrum of molecular defects in 216 Chinese families with hemophilia A: identification of noninversion mutation hot spots and 42 novel mutations" Clin Appl Thromb Hemost (2018) 10.1177/1076029616687848
[29]
J M Johnsen "Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative" Blood Adv (2017) 10.1182/bloodadvances.2016002923
[30]
Q Liang "A more universal approach to Comprehensive Analysis of Thalassemia Alleles (CATSA)" J Mol Diagn (2021) 10.1016/j.jmoldx.2021.06.008
[31]
Y Liu "Comprehensive analysis of congenital adrenal hyperplasia using long-read sequencing" Clin Chem (2022) 10.1093/clinchem/hvac046
[32]
S Li "Comprehensive analysis of spinal muscular atrophy: SMN1 copy number, intragenic mutation, and 2 + 0 carrier analysis by third-generation sequencing" J Mol Diagn (2022) 10.1016/j.jmoldx.2022.05.001
[33]
Q Liang "Comprehensive analysis of fragile X syndrome: full characterization of the FMR1 locus by long-read sequencing" Clin Chem (2022) 10.1093/clinchem/hvac154
[34]
M A Zimmermann "Unusual genomic rearrangements in introns 1 and 22 of the F8 gene" Hamostaseologie (2011) 10.1055/s-0037-1619754
[35]
F Jiang "Detection of rare thalassemia mutations using long-read single-molecule real-time sequencing" Gene (2022) 10.1016/j.gene.2022.146438
Metrics
22
Citations
35
References
Details
- Published
- Jun 07, 2023
- Vol/Issue
- 123(12)
- Pages
- 1151-1164
- License
- View
Authors
Funding
National Natural Science Foundation of China
Award: 82271752
National Key Research and Development Program of China
Award: 2022YFC2703700, 2022YFC2703400, 2021YFC1005302
Cite This Article
Yingdi Liu, Dongzhi Li, Dongyi Yu, et al. (2023). Comprehensive Analysis of Hemophilia A (CAHEA): Towards Full Characterization of the F8 Gene Variants by Long-Read Sequencing. Thrombosis and Haemostasis, 123(12), 1151-1164. https://doi.org/10.1055/a-2107-0702
Related
You May Also Like
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
F R Rosendaal, S C Cannegieter · 1993
1,656 citations
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis
Giuseppe Lippi, Emmanuel J. Favaloro · 2020
459 citations
Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients
Giulio Francesco Romiti, Daniele Pastori · 2021
341 citations
Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis
Lisa Jennings · 2009
293 citations